Advisory board to help guide selection of novel antibody-target pairs for ADC and T cell redirection modalities Antibody-drug conjugate and T cell redirection are two classes of treatment modalities ...
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrates encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...
The pneumococcal conjugate vaccines that were studied were the PCV10 (GSK) and PCV13 (Pfizer). The saccharide in PCV10 is conjugated to nontypable Haemophilus influenzae protein D, tetanus toxoid ...
What are the critical factors to bioconjugation success? Explore the workflow and learn how you can get started with quantitative and reproducible bioconjugation. SoluLINK bioconjugation technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback